Back
SPDR® S&P Telecom ETF Vs. Halozyme Therapeutics Industry Stock Comparison
Buy
59
XTL
SPDR® S&P Telecom ETF
Last Price:
105.04
Seasonality Move:
5.33%
Sell
35
HALO
Halozyme Therapeutics
Last Price:
42.56
Seasonality Move:
17.03%
Buy
59
SPDR® S&P Telecom ETF (XTL)
is a Buy
Is SPDR® S&P Telecom ETF a Buy, Sell or Hold?
- The current SPDR® S&P Telecom ETF [XTL] share price is $104.52. The Score for XTL is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- XTL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Halozyme Therapeutics (HALO)
is a Sell
Is Halozyme Therapeutics a Buy, Sell or Hold?
- The current Halozyme Therapeutics [HALO] share price is $42.57. The Score for HALO is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XTL Stock Price Chart
What is SPDR® S&P Telecom ETF's stock price today?
-
The SPDR® S&P Telecom ETF share price today is $104.52
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XTL is experiencing slight selling pressure.
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $42.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.
XTL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Sell |
| Relative Strength Index (14 RSI): | 53.07 | Buy |
| Chaikin Money Flow: | -3428 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
HALO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.04 | Sell |
| Relative Strength Index (14 RSI): | 26.84 | Sell |
| Chaikin Money Flow: | -3822578 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.96 - 58.72) | Sell |
| Bollinger Bands (100): | (51.86 - 60.48) | Sell |
XTL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0 | Buy |
| 20-day SMA: | 0 | Buy |
| 50-day SMA: | 0 | Buy |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 0 | Buy |
| 20-day EMA: | 0 | Buy |
| 50-day EMA: | 0 | Buy |
| 200-day EMA: | 0 | Buy |
HALO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.27 | Sell |
| 20-day SMA: | 54.02 | Sell |
| 50-day SMA: | 55.85 | Sell |
| 200-day SMA: | 48.97 | Sell |
| 8-day EMA: | 52.24 | Sell |
| 20-day EMA: | 54.19 | Sell |
| 50-day EMA: | 55.13 | Sell |
| 200-day EMA: | 50.65 | Sell |
SPDR® S&P Telecom ETF Earnings Growth & XTL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.
SPDR® S&P Telecom ETF Technical Analysis
| Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Halozyme Therapeutics Technical Analysis
| Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||